期刊文献+

Cuprizone介导的急性脱髓动物模型髓鞘脱失及再生的机制 被引量:1

MECHANISM OF DEMYELINATION AND REMYELINATION IN CUPRIZONE-INDUCED ACUTELY DEMYELINATED ANIMAL MODEL
暂未订购
导出
摘要 本研究通过在饲料中掺入cuprizone饲育小鼠,建立髓鞘可再生的急性脱髓动物模型,并利用髓鞘染色和原位杂交后免疫组化双标技术,检测髓鞘脱失和再生状况以及少突胶质前体细胞的改变。结果表明,给予cuprizone6周后,动物胼胝体严重脱髓鞘,少突胶质前体细胞在髓鞘脱失区域集聚,且增殖活跃;恢复正常饲料饲养4周后,髓鞘基本恢复正常形态。由此推测,在cuprizone介导的急性脱髓动物模型髓鞘脱失和再生过程中,少突胶质前体细胞的增殖活化为髓鞘再生提供了基础。 Cuprizone diet C57BL/6 mice were used to establish acutely demyelinated model in the present study. In these mice, status of demyelination and remyelination were studied by using myelin staining, and the changes of oligedendrocyte progenitors (OLPs) were demonstrated by immunohistochemistrical staining following in situ hybridization. The results showed that obvious demyelination and proliferation of OLPs occurred in corpus callosum following 6 weeks of exposure to cuprizone, and myelin became normal by remyelination after the mice were returned to 4 weeks of normal diet. It suggests that proliferation of OLPs is contributed to remyelination in cuprizone induced acutely demyelinated animal model.
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2007年第2期191-194,共4页 Chinese Journal of Neuroanatomy
基金 辽宁省科技厅博士启动基金(No.20051071)资助项目
关键词 CUPRIZONE 脱髓鞘 少突胶质前体细胞 动物模型 cuprizone, demyelination, oligodendrocyte progenitor
  • 相关文献

参考文献12

  • 1Mason JL, Toews A, Hostettler JD et al. Oligedendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol, 2004 ; 164 : 1673 - 1682.
  • 2Chang A, Tourtellotte WW, Rudick R et al. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med,2002; 346:165 - 173.
  • 3Takebayashi H, Yoshida S, Sugimori Met al. Dynamic expression of basic helix-loop-helix Oligo family members: implication of Oligo2 in neuron and oligodendrocyte differentiation and identification of a new member, Oligo3. Mechanism of Development, 2000 ;99 :143 - 148.
  • 4Moreil P, Barrett CV, Mason JL et al. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol Cell Neurosci, 1998 ; 12:220 - 227.
  • 5Hiremath MM, Saito Y, Knapp GW et al. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol, 1998 ;92:38 - 49.
  • 6Glenn K, Matsushima and Morell P. The neurotoxicant, cuprizone,as a model to study demyelination and remyelination in the central nervous system. Brain Pathology, 2001 ;11:107 - 116.
  • 7Levison SW, Goldman JE. Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron, 1993 ;10:201 - 212.
  • 8Ono K, Yasui Y, Rutishayser U et al. Focal ventricular origin and migration of oligodendrocyte precursors into the chick optic nerve.Neuron, 1997 ; 19:283 - 292.
  • 9Hajihosseini M, Than TN, Dubois-Dalcq M. Origin of oligodendrocytes within the human spinal cord. J Neurosci, 1996;16:7981 -7994.
  • 10Mason JL, Jones J, Taniike Met al. Mature oligedendrocyte apoptosis precedes IGF production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res, 2000 ;61:251 - 262.

同被引文献16

  • 1宋大为,范凯,张艳丽,马坚妹.星形胶质细胞在cuprizone介导的急性脱髓动物模型中的变化及其意义[J].中国临床解剖学杂志,2007,25(5):540-542. 被引量:3
  • 2Mason JL, Toews A, Hostettler JD et al. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Patbol, 2004 ; 164 : 1673 - 1682.
  • 3Chang A, Tourtellotte WW, Rudick R et al. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med, 2002 ;346 : 165 - 173.
  • 4Bever CT Jr, Garver DW. Increased cathepsin B activity in multiple sclerosis brain. J Neurol Sci, 1995;131:71 -73.
  • 5Nagai A, Murakawa Y, Terashima Met al. Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases. Neurology, 2000 ;55 : 1828 - 1832.
  • 6Berdowska I. Cysteine proteases as disease markers. Clin Chim Acta, 2004;342:41 -69.
  • 7Brzin J, Popovic T, Turk Vet al. Human cystatin, a new protein inhibitor of cysteine proteinases. Biochem Biophys Res Commun, 1984;118:103 - 109.
  • 8Barrett AJ, Davies ME, Grubb A et al. The place of human gamma-trace (cystatin C ) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun, 1984 ; 120:631 - 636.
  • 9Grubb AO. Cystatin C-properties and use as diagnostic marker. Adv Clin Chem, 2000;35:63 -99.
  • 10Lecaille F, Kaleta J, Bromme D. Human and parasitic papain-like cysteine proteases : their role in physiology and pathology and recent developments in inhibitor design. Chem Rev, 2002;102:4459 - 4488.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部